Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Electron Secures $250M in Revolving Credit Through 2009

NEW YORK, Dec. 21 (GenomeWeb News) - Thermo Electron has signed a five-year agreement for up to $250 million in a revolving line of credit with Barclays Bank, Thermo disclosed yesterday in an SEC filing.

 

The agreement replaces existing one-year and three-year credit agreements, which were set to expire on Dec. 17, 2004 and Dec. 20, 2005, respectively.

 

The aggregate amount of the credit may be increased at Thermo's request by up to $100 million, the filing states.

 

The company said in the filing that it has not borrowed any amount under the current or prior credit agreements.

The Scan

Study Reveals Details of SARS-CoV-2 Spread Across Brazil

A genomic analysis in Nature Microbiology explores how SARS-CoV-2 spread into, across, and from Brazil.

New Study Highlights Utility of Mutation Testing in Anaplastic Thyroid Cancer

Genetic mutations in BRAF and RAS are associated with patient outcomes in anaplastic thyroid carcinoma, a new JCO Precision Oncology study reports.

Study Points to Increased Risk of Dangerous Blood Clots in COVID-19 Patients

An analysis in JAMA Internal Medicine finds that even mild COVID-19 increases risk of venous thromboembolism.

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.